AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

$22 Million Boost for Australian Cancer Clinical Trials to Enhance Research and Access

7 months ago

• Australia's cancer clinical trials receive a $22.19 million funding boost to support 14 multi-site Collaborative Cancer Clinical Trials Groups (CTGs) nationwide. • The funding, administered by Cancer Australia, aims to improve clinical trial design, enhance equitable access, and accelerate research translation into clinical practice. • The program prioritizes addressing unmet needs, including rare cancers, and improving access to optimal cancer care, especially in rural and Indigenous communities. • The initiative aligns with the Australian Cancer Plan, focusing on reducing cancer's impact and improving outcomes through targeted and innovative research investment.